Wall Street is set to see six new issuers debut on the market this week, raising an expected total of about $5 billion, led by First Data's $3 billion IPO. For the full IPO calendar HERE.
Here are the expected IPOs for the week of October 12, ranked by size:
(1) Based in New York, NY,First Data (FDC) scheduled a $3 billion IPO on NYSE with a market capitalization of $16.7 billion at a price range midpoint of $19 for Thursday, October 15, 2015.
First Data sits at the center of global electronic commerce.
FDC believes it offers its clients the most complete array of integrated solutions in the industry, covering their needs across next-generation commerce technologies, merchant acquiring, issuing, and network solutions.
FDC serves its clients in 118 countries, reaching approximately 6 million business locations and over 4,000 financial institutions.
(2) Based in Boise, ID,Albertsons Companies (ABS) scheduled a $1.6 million IPO on NYSE with a market capitalization of $11.6 billion at a price range midpoint of $24.50 for Thursday, October 15 2015.
ABS is one of the largest food and drug retailers in the United States, with both strong local presence and national scale.
As of June 20, 2015, ABS operated 2,205 stores across 33 states under 18 well-known banners, including Albertsons, Safeway, Vons, Jewel-Osco, Shaw’s, Acme, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market and Carrs.
(3) Based in New York, NY,American Farmland (AFCO) scheduled a $114 million IPO on NYSE with a market capitalization of $218 million at a price range midpoint of $9.50 for Friday, Oct. 16, 2015.
AFCO is an internally managed real estate company that owns a diversified portfolio of high-quality farmland, consisting of mature permanent, specialty/vegetable row and commodity row crop farms, as well as farmland development projects, which is located in select major agricultural regions in the United States.
AFCO seeks to provide its stockholders with a combination of (i) current income from renting its stable portfolio of mature farms and (ii) capital appreciation, partially driven by its ability to develop properties to maximize their value.
(4) Based in Sunnyvale, CA,Adesto Technologies (IOTS) scheduled a $45 million IPO on Nasdaq with a market capitalization of $153 million at a price range midpoint of $11 for Friday, October 16, 2015.
IOTS is a leading provider of application-specific, feature-rich, ultra-low power non-volatile memory products.
IOTS optimizes its non-volatile memory products for Internet of Things, or IoT, applications including current and next-generation Internet-connected devices in the consumer, industrial, medical and wearables markets.
(5) Based in Tucson, AZ,SynCardia Systems (TAHT) scheduled a $28 million IPO on Nasdaq with a market capitalization of $86 million at a price range midpoint of $11 for the week of October 12, 2015.
TAHT is a medical technology company focused on developing, manufacturing and commercializing the SynCardia temporary Total Artificial Heart, or TAH-t, an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.
The SynCardia TAH-t is the only total artificial heart that is commercially available in the United States, European Union and Canada for use as a bridge to heart transplantation.
(6) Holdover: Based in Baltimore, MD,Cerecor (CERC) scheduled a $28 million IPO on Nasdaq with a market capitalization of $58 million at a price range midpoint of $6.50 for the week of October 5, 2015.
CERC is a clinical-stage biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric disorders.
CERC has a portfolio of clinical and preclinical compounds that CERC believes are best-in-class due to their unique mechanism of action and where human proof of concept has been established for the compound or the target.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer